Tyndall Capital Partners L P
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Tyndall Capital Partners L P reported 1 stock position worth $452 thousand. Its top holding was Cyclerion Therapeutics at 100.0% of the portfolio. Compared with Q1 2025, it reduced 1. The biggest sale was Cyclerion Therapeutics (shares −6%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001219314
- Portfolio Value
- $452K (Q2 2025)
- SEC Filing
- 0001641172-25-023976 ↗ filed Aug 14, 2025
Holdings Value
Holdings 1 stocks · $452K
| CYCLERION THERAPEUTICS INC | 100.00% | 155,187 | $452K | Reduce -5.8% |
Portfolio Sells Q1 2025 → Q2 2025
| CYCLERION THERAPEUTICS INC | Reduce -5.8% | 100.00% | 0.00 |
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 0 | $0 | |
| Q4 2025 | 0 | $0 | |
| Q3 2025 | 0 | $0 | |
| Q2 2025 | 1 | $452K | CYCLERION THERAPEUTICS INC |
| Q1 2025 | 1 | $412K | CYCLERION THERAPEUTICS INC |
| Q4 2024 | 1 | $531K | CYCLERION THERAPEUTICS INC |
| Q3 2024 | 1 | $427K | CYCLERION THERAPEUTICS INC |
| Q2 2024Amended | 1 | $379K | CYCLERION THERAPEUTICS INC |
| Q1 2024 | 1 | $527K | CYCLERION THERAPEUTICS INC |